EUVIMEDEUVIMED entdecken
Open Access

Engineering Iron Oxide Nanoparticles for Clinical Settings

Aitziber L Cortajarena, Daniel Ortega, Sandra M Ocampo, Alberto Gonzalez-García, Pierre Couleaud, Rodolfo Miranda, Cristobal Belda-Iniesta, Angel Ayuso-Sacido

Nanobiomedicine · 2014

DOI: 10.5772/58841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanobiomedicine, 2014. Verfasst von Aitziber L Cortajarena und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Madrileño de Estudios Avanzados IMDEA-Nanociencia, Madrid, Spain. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron oxide nanoparticles (IONPs) occupy a privileged position among magnetic nanomaterials with potential applications in medicine and biology. They have been widely used in preclinical experiments for imaging contrast enhancement, magnetic resonance, immunoassays, cell tracking, tissue repair, magnetic hyperthermia and drug delivery. Despite these promising results, their successful translation into a clinical setting is strongly dependent upon their physicochemical properties, toxicity and functionalization possibilities. Currently, IONPs-based medical applications are limited to the use of non-functionalized IONPs smaller than 100 nm, with overall narrow particle size distribution, so that the particles have uniform physical and chemical properties. However, the main entry of IONPs into the scene of medical application will surely arise from their functionalization possibilities that will provide them with the capacity to target specific cells within the body, and hence to play a role in the development of specific therapies. In this review, we offer an overview of their basic physicochemical design parameters, giving an account of the progress made in their functionalization and current clinical applications. We place special emphasis on past and present clinical trials.

Schlagwörter

Stichwörter der Autor:innen

Drug DeliveryIONPIron Oxide NanoparticlesMRIMagnetic HyperthermiaNanomedicineSPIONUSPIONVSPION

Autor:innen und Institutionen

  • Instituto Madrileño de Estudios Avanzados IMDEA-Nanociencia, Madrid, Spain.
  • Centro Nacional de Biotecnología (CNB-CSIC) - IMDEA Nanociencia Associated Unit "Unidad de Nanobiotecnología", Cantoblanco, Madrid, Spain.
  • Institute of Biomedical Engineering, University College London, UK.
  • Centro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA). Hospital de Madrid Foundation, Madrid, Spain.
  • National School of Health, ISCIII, Madrid, Spain.

Zitieren

APA

Cortajarena, A. L., Ortega, D., Ocampo, S. M., Gonzalez-García, A., Couleaud, P., Miranda, R., Belda-Iniesta, C., & Ayuso-Sacido, A. (2014). Engineering Iron Oxide Nanoparticles for Clinical Settings. Nanobiomedicine. https://doi.org/10.5772/58841

Vancouver

Cortajarena AL, Ortega D, Ocampo SM, Gonzalez-García A, Couleaud P, Miranda R, et al. Engineering Iron Oxide Nanoparticles for Clinical Settings. Nanobiomedicine. 2014. doi:10.5772/58841

BibTeX
@article{Cortajarena2014,
  author = {Cortajarena, Aitziber L and Ortega, Daniel and Ocampo, Sandra M and Gonzalez-García, Alberto and Couleaud, Pierre and Miranda, Rodolfo and Belda-Iniesta, Cristobal and Ayuso-Sacido, Angel},
  title = {Engineering Iron Oxide Nanoparticles for Clinical Settings},
  journal = {Nanobiomedicine},
  year = {2014},
  doi = {10.5772/58841}
}
Kostenlos starten →